Dr Karthika Radhakrishnan is a member of the Leukaemia Modelling and Therapeutic Discovery Research group in the Centre for Cancer Research.
Areas of interest
Dr Karthika Radhakrishnan is a post-doctoral researcher working with Dr Catherine Carmichael in the Leukaemia Modelling and Therapeutic Discovery Research group, Centre for Cancer Research.
After completing her PhD in Reproductive Biology, Dr Radhakrishnan joined the Testis Development and Germ Cell Biology research group in the Centre for Reproductive Health at Hudson Institute in 2018 to understand the role of TGF-β signalling pathway in testicular germ cell development. Her work highlighted the role of nuclear transport protein, IPO5, in modulating TGF-β signalling pathway in the testicular cancer cells.
She joined the Leukaemia Modelling and Therapeutic Discovery research group in mid-2022, and her current research involves elucidating the molecular mechanism driving the development and pathogenesis of Acute Erythroid Leukaemia.